Taipei Medical University

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Chen BC
------>authors3_c=???
------>paper_class1=1
------>Impact_Factor=5.581
------>paper_class3=2
------>paper_class2=1
------>vol=284
------>confirm_bywho=chshih43
------>insert_bywho=bcchen
------>Jurnal_Rank=15.2
------>authors4_c=???
------>comm_author=
------>patent_EDate=None
------>authors5_c=???
------>publish_day=31
------>paper_class2Letter=None
------>page2=20573
------>medlineContent=
------>unit=E0400
------>insert_date=20090702
------>iam=1
------>update_date=None
------>author=???
------>change_event=4
------>ISSN=
------>authors_c=???
------>score=488
------>journal_name=The Journal of Biological Chemistry
------>paper_name=Peptidoglycan induces cyclooxygenase-2 expression in macrophages by activating the neutral sphinomylinase-ceramide pathway
------>confirm_date=20090825
------>tch_id=091057
------>pmid=19531467
------>page1=20562
------>fullAbstract=The sphingomyelin signal transduction pathway is known to play a role in mediating the action of various cytokines. Herein, we examined the role of neutral sphingomyelinase (nSMase)/ceramide in peptidoglycan (PGN)-induced NF-kappaB activation and cyclooxygenase-2 (COX-2) expression in macrophages. PGN-induced COX-2 expression was attenuated by an nSMase inhibitor (3-O-methyl-sphingomyeline, 3-OMS) and ceramidase, but not by an acidic SMase inhibitor (imipramine). C2-ceramide, bacterial SMase (which mimics cellular SMase activity), and a ceramidase inhibitor (N-oleoyl-ethanolamine) individually had no effect on COX-2 expression; however, they markedly enhanced PGN-induced COX-2 expression. PGN activated nSMase, but not acidic SMase, resulting in increased ceramide generation. PGN-induced nSMase activation and ceramide formation were inhibited by 3-OMS, but not by imipramine. PGN-induced COX-2 expression was inhibited by a p38 MAPK inhibitor (SB 203580) and dominant negative mutants of MAPK kinase (MKK) 3, MKK6, and p38 MAPKalpha. 3-OMS selectively inhibited PGN-induced p38 MAPK and MKK3/6 activation, but not JNK or ERK1/2. C2-ceramide, bacterial SMase, and N-oleoyl-ethanolamine all induced p38 MAPK or MKK3/6 activation. The PGN-mediated increases in kappaB-luciferase activity were also inhibited by 3-OMS and the p38 MAPKalphaDN, but not by imipramine. Furthermore, C2-ceramide caused an increase in kappaB-luciferase activity. Our data demonstrate for the first time that PGN activates the nSMase/ceramide pathway to induce MKK3/6/p38 MAPK activation, which in turn initiates NF-kappaB activation and ultimately induces COX-2 expression in macrophages. The nSMase/ceramide pathway is required but might not be sufficient for COX-2 expression induced by PGN.
------>tmu_sno=None
------>sno=22002
------>authors2=Chang HM
------>authors3=Hsu MJ
------>authors4=Shih CM
------>authors5=Chiu YH
------>authors6=Chiu WT, Lin CH
------>authors6_c=???,???
------>authors=Chen BC
------>delete_flag=0
------>SCI_JNo=None
------>authors2_c=???
------>publish_area=0
------>updateTitle=Peptidoglycan induces cyclooxygenase-2 expression in macrophages by activating the neutral sphingomyelinase-ceramide pathway.
------>language=2
------>check_flag=None
------>submit_date=None
------>country=None
------>no=31
------>patent_SDate=None
------>update_bywho=None
------>publish_year=2009
------>submit_flag=None
------>publish_month=7
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z